Presented at ACC as a Late-Breaking Clinical Trial, VALOR-HCM explores Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive…
Luke Laffin, MD, cardiologist in the Section of Preventive Cardiology at Cleveland Clinic discusses his recently published paper with Stephanie Besser, MSA, MSPA, and Francis Alenghat, MD, PhD,…